Device / Technology News

RSS

CAP publishes revised version of molecular pathology checklist with dedicated section on NGS

The College of American Pathologists (CAP) published a revised version of its molecular pathology checklist with a dedicated section on next generation sequencing (NGS) as part of the new edition of the CAP Laboratory Accreditation Program checklists released July 31, 2012.

2 Aug 2012

Researchers unlock genetic secrets of peripheral T-cell lymphomas

Researchers at Mayo Clinic have completed the world's first genome-wide sequencing analysis of peripheral T-cell lymphomas, unlocking the genetic secrets of this poorly understood and highly aggressive cancer of the immune system.

2 Aug 2012

Endoscopic vein-graft harvesting technique safe for CABG surgery

Although there have been questions regarding the safety and durability of endoscopic vein graft harvest for coronary artery bypass graft (CABG) surgery, an analysis of data of more than 200,000 patients who underwent CABG surgery found no evidence of a long-term increased risk of death with endoscopic vein graft harvesting compared to open vein-graft harvesting, according to a study in the August 1 issue of JAMA.

1 Aug 2012

Researchers develop bioactive coating that actively suppresses brain's immune response

Brain-computer interfaces are at the cutting edge for treatment of neurological and psychological disorder, including Parkinson's, epilepsy, and depression. Among the most promising advance is deep brain stimulation (DBS) - a method in which a silicon chip implanted under the skin ejects high frequency currents that are transferred to the brain through implanted electrodes that transmit and receive the signals.

1 Aug 2012

U of I professor develops new algorithm for dietitians

If you've consulted with a nutrition educator about how best to lose weight or manage your diabetes, high blood pressure, or high cholesterol, you may not have learned as much as you could have, said a University of Illinois professor of nutrition extension.

1 Aug 2012

Cervical cancer screening product from DySIS Medical recommended by NICE

DySIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Health and Clinical Excellence (‘NICE’) has today published positive diagnostics guidance recommending its DySIS cervical cancer screening product to be considered in procurement plans.

1 Aug 2012

Stemgent acquires Asterand’s Human Tissue Business for $9 million

Stemgent, Inc. announced today that it has completed the acquisition of Asterand Plc's Human Tissue Business for $9 million. Asterand provides a set of high quality, human-tissue based tools for drug and drug target discovery that is highly complementary to Stemgent's growing portfolio of innovative research products and services to advance cellular reprograming and stem cell research.

1 Aug 2012

Intraluminal protection device outperforms two negative-pressure IV connectors in MECH research

An IV connector known as an intraluminal protection device (IPD) significantly outperformed two widely used negative-pressure IV connectors in research performed at Methodist Extended Care Hospital (MECH).

1 Aug 2012

Minimally invasive approach during coronary artery bypass grafting surgery is safe and effective

New research shows that a minimally invasive approach used during coronary artery bypass grafting (CABG) surgery is safe and effective, despite previous studies that linked endoscopic vein harvesting (EVH) to a higher mortality rate.

1 Aug 2012

MDxHealth’s Irvine, California and CLIA laboratory receive CAP accreditation

MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laboratory has received College of American Pathology (CAP) accreditation.

1 Aug 2012

IL-10 may improve success rates of skin autografts

Scientists have found that the anti-inflammatory molecule, IL-10, may improve success rates of skin autografts (skin moved from one site of the body to another). This information provides a valuable drug target that may benefit burn and accident victims.

1 Aug 2012

GE Healthcare, Intermountain partner to help reduce radiation dose in CT procedures by 50%

Intermountain Healthcare today announced a joint effort with GE Healthcare to help further reduce radiation dose in Computed Tomography (CT) procedures at its facilities by up to 50 percent.

31 Jul 2012

FDA clears Reflectance Medical's CareGuide Oximeter

Reflectance Medical, a commercial-stage company focused on the development of physiologic sensors to non-invasively and continuously assess patient metabolic status, announced today that it has received FDA 510(k) clearance for its initial product, the CareGuide Oximeter.

31 Jul 2012

NYGC purchases four Life Technologies' Ion Proton Sequencers

Life Technologies Corporation today announced that the New York Genome Center (NYGC) has purchased four Ion Proton Sequencers for its new Innovation Center.

31 Jul 2012

Infuse Medical launches EtherDCP Mobile Application Management platform

Infuse Medical, a premier provider of mobile apps and content for the medical device market, today formally unveiled EtherDCP, an advanced Mobile Application Management (MAM) platform.

31 Jul 2012

Rye Radiology offers new 3D mammography that detects many breast cancers

Rye Radiology Associates, LLP, became the first facility between Manhattan and Syracuse to offer the new FDA-approved 3D mammography which finds more breast cancers than traditional mammography.

31 Jul 2012

Alseres enters agreement with Navidea to license Altropane imaging agent

Alseres Pharmaceuticals, Inc. today announced that it has entered into an agreement with Navidea Biopharmaceuticals, Inc. to license, [123I]-E-IACFT Injection (CFT), also called Altropane, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson's disease and movement disorders.

31 Jul 2012

Population Genetics validates GenomePooling™ for cancer

Population Genetics Technologies Ltd., creator of innovative methods for genetic analyses and biomarker discovery, has successfully completed a pilot study to prove that its GenomePooling™ method is sensitive and accurate enough to detect even small percentages of gene variants within cancer tissue. This validates the method’s suitability for use in IntReALL 2010, the world’s largest genetic analysis of acute lymphoblastic leukaemia (ALL) relapse cases. ALL is the most common childhood malignant disease.

31 Jul 2012

E-nose detects malignant mesothelioma

Australian researchers have developed a breath test using an electronic nose to help diagnose malignant mesothelioma in its early stages, a potentially life-saving move.

31 Jul 2012